Latest Diagnostics Commercialisation News

Page 1 of 1

AnteoTech receives $1.91 million R&D rebate to fund battery and life sciences push

AnteoTech has received $1.905 million from the Australian R&D Tax Incentive, providing fresh cash for its battery materials and life sciences commercialisation efforts. The rebate relates to eligible research conducted during the 2026 financial year.

Sophie Babbage

29 Sept 2026

Proteomics International Cuts 25% Staff, Appoints CFO, Signals Commercial Shift

Proteomics International Laboratories has slashed a quarter of its workforce and appointed a new CFO amid a strategic pivot to commercial diagnostics, aiming to save over $1 million annually and sharpen execution.

Ada Torres

17 Apr 2026

Browse the archive

Full archive

Oct 2026 Sept 2026 Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026